Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Conditions: HER2-positive Breast Cancer; Breast Cancer Metastatic Interventions: Drug: Palbociclib 75mg; Drug: Letrozole 2.5mg; Drug: T-DM1; Drug: Palbociclib 100mg; Drug: Palbociclib 125mg; Drug: Palbociclib Sponsors: University of Kansas Medical Center; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials